Philip B. Hylemon

2.2k citations

30 papers · 1.9k indexed · h-index 22

Hepatology top 2%
- Liver physiology and pathology 5
Oncology top 5%
- Drug Transport and Resistance Mechanisms 14
- Cancer-related Molecular Pathways 6
Epidemiology top 5%
- Liver Disease Diagnosis and Treatment 5
- Autophagy in Disease and Therapy 3
Pharmacology top 2%
- Drug-Induced Hepatotoxicity and Protection 4
Surgery top 5%
Molecular Biology
- Cell death mechanisms and regulation 7
Cell Biology
- Aldose Reductase and Taurine 3

Co-authors: Paul Dent Steven Grant Douglas M. Heuman Reno Z. Vlahcevic Seema Gupta Liang Qiao Elaine Studer Paul B. Fisher
Cited by: Hepatology Oncology Epidemiology
Journals: Journal of Biological Chemistry (2 papers)Gastroenterology (1 paper)Molecular and Cellular Biology (1 paper)
Partner nations: United States United Kingdom France

In The Last Decade

Philip B. Hylemon

30 papers receiving 1.9k citations

Peers

Countries citing papers authored by Philip B. Hylemon

Since Specialization

Citations

This map shows the geographic impact of Philip B. Hylemon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip B. Hylemon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip B. Hylemon more than expected).

Fields of papers citing papers by Philip B. Hylemon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip B. Hylemon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip B. Hylemon. The network helps show where Philip B. Hylemon may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Philip B. Hylemon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Philip B. Hylemon Line = papers co-authored together Philip B. Hylemon links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Astrocyte Elevated Gene-1 (AEG-1) Regulates Lipid Homeostasis Journal of Biological Chemistry ·Chadia L. Robertson,Jyoti Srivastava,Ayesha Siddiq,Rachel Gredler,Luni Emdad,Devaraja Rajasekaran,Maaged Akiel,Xue‐Ning Shen,Frank Corwin,Gobalakrishnan Sundaresan,Jamal Zweit,Colleen M. Croniger,Xiaoli Gao,Shobha Ghosh,Philip B. Hylemon,Mark A. Subler,Jolene J. Windle,Paul B. Fisher,Devanand Sarkar	2015	19
2	A longitudinal systems biology analysis of lactulose withdrawal in hepatic encephalopathy Metabolic Brain Disease ·Jasmohan S. Bajaj,Patrick M. Gillevet,Neeral R. Patel,Vishwadeep Ahluwalia,Jason M. Ridlon,Birgit Kettenmann,Christine M. Schubert,Masoumeh Sikaroodi,Douglas M. Heuman,Mary M.E. Crossey,Debulon E. Bell,Philip B. Hylemon,Panos P. Fatouros,Simon D. Taylor‐Robinson	2012	76
3	Vorinostat and sorafenib increase ER stress, autophagy and apoptosis via ceramide-dependent CD95 and PERK activation Cancer Biology & Therapy ·Margaret A. Park,Guo Zhang,Aditi Pandya Martin,Hossein A. Hamed,Clint Mitchell,Philip B. Hylemon,Martin R. Graf,Mohamed Rahmani,Kevin M. Ryan,Xiang Liu,Sarah Spiegel,James N. Norris,Paul B. Fisher,Steven Grant,Paul Dent	2008	146
4	Regulation of autophagy by ceramide-CD95-PERK signaling Autophagy ·Margaret A. Park,Guo Zhang,James N. Norris,Philip B. Hylemon,Paul B. Fisher,Steven Grant,Paul Dent	2008	28
5	Conjugated Bile Acids Regulate Hepatocyte Glycogen Synthase Activity In Vitro and In Vivo via Gαi Signaling Molecular Pharmacology ·Youwen Fang,Elaine Studer,Clint Mitchell,Steven Grant,William M. Pandak,Philip B. Hylemon,Paul Dent	2007	40
6	Conjugated bile acids promote ERK1/2 and AKT activation via a pertussis toxin–sensitive mechanism in murine and human hepatocytes† Hepatology ·Paul Dent,Youwen Fang,Seema Gupta,Elaine Studer,Clint Mitchell,Sarah Spiegel,Philip B. Hylemon	2005	100
7	Bile acids enhance the activity of the insulin receptor and glycogen synthase in primary rodent hepatocytes Hepatology ·Song Iy Han,Elaine Studer,Seema Gupta,Youwen Fang,Liang Qiao,Weiqun Li,Steven Grant,Philip B. Hylemon,Paul Dent	2004	52
8	Regulation of p21 and p27 expression by the hepatitis B virus X protein and the alternate initiation site X proteins, AUG2 and AUG3 Journal of Gastroenterology and Hepatology ·J. Kevin Leach,Liang Qiao,Youwen Fang,SONG LY HAN,Donna Gilfor,Paul B. Fisher,Steven Grant,Philip B. Hylemon,Darrell L. Peterson,Paul Dent	2003	11
9	Fas Ligand-dependent and -independent mechanisms of toxicity induced by T cell lymphomas in lymphoid organs and in the liver Clinical Immunology ·Catherine Lombard,Robert J. McKallip,Philip B. Hylemon,Prakash Nagarkatti	2003	6
10	Cyclin kinase inhibitor p21 potentiates bile acid-induced apoptosis in hepatocytes that is dependent on p53 Hepatology ·Liang Qiao,Robert McKinstry,Seema Gupta,Donna Gilfor,Jolene J. Windle,Philip B. Hylemon,Steven Grant,Paul B. Fisher,Paul Dent	2002	40
11	Inhibition of the MAPK and PI3K pathways enhances UDCA-induced apoptosis in primary rodent hepatocytes Hepatology ·Liang Qiao,Adly Yacoub,Elaine Studer,Seema Gupta,Xin Pei,Steven Grant,Philip B. Hylemon,Paul Dent	2002	123
12	Hepatitis B virus X protein increases expression of p21Cip-1/WAF1/MDA6 and p27Kip-1 in primary mouse hepatocytes, leading to reduced cell cycle progression Hepatology ·Liang Qiao,Kevin Leach,Robert McKinstry,Donna Gilfor,Adly Yacoub,Jong Sung Park,Steven Grant,Philip B. Hylemon,Paul B. Fisher,Paul Dent	2001	52
13	A Role for Both Ets and C/EBP Transcription Factors and mRNA Stabilization in the MAPK-dependent Increase in p21^{Cip-1/WAF1/mda6}Protein Levels in Primary Hepatocytes Molecular Biology of the Cell ·Jong Sung Park,Liang Qiao,Donna Gilfor,Ming Yang,Philip B. Hylemon,Christopher C. Benz,Gretchen Darlington,Gary L. Firestone,Paul B. Fisher,Paul Dent	2000	68
14	Positive and negative regulation of JNK1 by protein kinase C and p42^{MAP kinase} in adult rat hepatocytes FEBS Letters ·W. David Jarvis,Kelly L. Auer,Mark S. Spector,George Kunos,Steven Grant,Philip B. Hylemon,Ross B. Mikkelsen,Paul Dent	1997	30
15	Molecular cloning and expression of rat hepatic neutral cholesteryl ester hydrolase Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism ·Shobha Ghosh,Darrell H. Mallonee,Philip B. Hylemon,William Grogan	1995	55
16	Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile salts Gastroenterology ·Douglas M. Heuman,A. Scott Mills,Janice D. McCall,Philip B. Hylemon,William M. Pandak,Z. Reno Vlahčevič	1991	204
17	Conjugates of ursodeoxycholate protect against cytotoxicity of more hydrophobic bile salts: In vitro studies in rat hepatocytes and human erythrocytes Hepatology ·Douglas M. Heuman,Michael W. Pandak,Philip B. Hylemon,Reno Z. Vlahcevic	1991	192
18	Altered levels of phosphoinositide metabolites and activation of guanine‐nucleotide dependent phospholipase C in rat hepatic tumors Journal of Cellular Physiology ·Narendra D. Lalwani,Philip B. Hylemon,Stephen C. Strom	1991	11
19	Cholesterol and Bile Acid Metabolism in Cultures of Primary Rat Bile Ductular Epithelial Cells Hepatology ·Philip B. Hylemon,Patricia Bohdan,Alphonse E. Sirica,Douglas M. Heuman,Reno Z. Vlahcevic	1990	14
20	Regulation of bile acid synthesis. I. Effects of conjugated ursodeoxycholate and cholate on bile acid synthesis in chronic bile fistula rat Hepatology ·Douglas M. Heuman,Carmen R. Hernandez,Philip B. Hylemon,William M. Kubaska,Constance Hartman,Reno Z. Vlahcevic	1988	66

About Philip B. Hylemon

Philip B. Hylemon is a scholar working on Hepatology, Oncology and Pharmacology, having authored 30 papers that have together received 1.9k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (14 papers), Cell death mechanisms and regulation (7 papers), Cancer-related Molecular Pathways (6 papers), Liver physiology and pathology (5 papers), Liver Disease Diagnosis and Treatment (5 papers), Drug-Induced Hepatotoxicity and Protection (4 papers), Aldose Reductase and Taurine (3 papers) and Autophagy in Disease and Therapy (3 papers). The work is most often cited by research in Hepatology (437 citations), Oncology (949 citations) and Epidemiology (694 citations). Philip B. Hylemon has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Paul Dent, Steven Grant, Douglas M. Heuman, Reno Z. Vlahcevic, Seema Gupta, Liang Qiao, Elaine Studer, Paul B. Fisher, William M. Pandak and Douglas M. Heuman. Their work appears in journals such as Journal of Biological Chemistry, Gastroenterology and Molecular and Cellular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact